Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Primary squamous cell carcinoma of the breast: achieving long-term control with cisplatin-based chemotherapy.

Bhatt L, Fernando I.

Clin Breast Cancer. 2009 Aug;9(3):187-8. doi: 10.3816/CBC.2009.n.031.

PMID:
19661044
2.

Primary squamous cell carcinoma of the breast: sensitivity to cisplatinum-based chemotherapy.

Dejager D, Redlich PN, Dayer AM, Davis HL, Komorowski RA.

J Surg Oncol. 1995 Jul;59(3):199-203.

PMID:
7609529
3.

Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: results of a phase II study.

Vrdoljak E, Prskalo T, Omrcen T, Situm K, Boraska T, Frleta Ilić N, Janković S, Hamm W.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):824-9.

PMID:
15708262
4.

Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.

Hung A, Crane C, Delclos M, Ballo M, Ajani J, Lin E, Feig B, Skibber J, Janjan N.

Cancer. 2003 Mar 1;97(5):1195-202.

5.

Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.

Souquet PJ, Fournel P, Bohas CH, Fortune IC, Chatte G.

Semin Oncol. 1996 Apr;23(2 Suppl 5):8-10.

PMID:
8610239
6.

A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study.

Moore DH, Ali S, Koh WJ, Michael H, Barnes MN, McCourt CK, Homesley HD, Walker JL.

Gynecol Oncol. 2012 Mar;124(3):529-33. doi: 10.1016/j.ygyno.2011.11.003. Epub 2011 Nov 9.

PMID:
22079361
7.

[A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases].

Hiramatsu K, Kato K, Hirata A, Matsuba H, Hara T, Ito T, Miyata T, Akagawa T, Kutsuna Y, Machiki Y, Fujioka S.

Gan To Kagaku Ryoho. 2007 Mar;34(3):443-6. Japanese.

PMID:
17353640
8.

Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix.

Kodama J, Takemoto M, Seki N, Nakamura K, Hongo A, Moriya S, Kanazawa S, Hiramatsu Y.

Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1300-4. doi: 10.1111/j.1525-1438.2008.01199.x. Epub 2008 Feb 15.

PMID:
18284451
9.
11.

High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx.

Lacava JA, Ferreyra R, Leone BA, Losada C, Elem YL, Vallejo CT.

Cancer J Sci Am. 1996 Jan-Feb;2(1):46-51.

PMID:
9166498
12.

concomitant chemoradiotherapy with mitomycin C and cisplatin in advanced unresectable carcinoma of the head and neck: phase I-II clinical study.

Strojan P, Karner K, Smid L, Soba E, Fajdiga I, Jancar B, Anicin A, Budihna M, Zakotnik B.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):365-72. doi: 10.1016/j.ijrobp.2007.12.060. Epub 2008 Apr 18.

PMID:
18394816
13.

Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.

Mantovani G, Ghiani M, Lai P, Maccio A, Dessi D, Succu G, Massa D, Curreli L, Mulas C, Esu S, Proto E, Cadeddu G, Tore G.

Oncol Rep. 1998 Nov-Dec;5(6):1499-505.

PMID:
9769395
14.

Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.

Edmonson JH, Petersen IA, Shives TC, Mahoney MR, Rock MG, Haddock MG, Sim FH, Maples WJ, O'Connor MI, Gunderson LL, Foo ML, Pritchard DJ, Buckner JC, Stafford SL.

Cancer. 2002 Feb 1;94(3):786-92.

15.

[Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].

Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.

Cancer Radiother. 2004 Jun;8(3):155-67. French.

PMID:
15217583
16.
17.

A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.

Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.

Gynecol Oncol. 2009 Jan;112(1):85-9. doi: 10.1016/j.ygyno.2008.09.029. Epub 2008 Nov 1.

18.

Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer. Long-term results.

Colozza M, Gori S, Mosconi AM, Anastasi P, de Angelis V, Giansanti M, Mercati U, Aristei C, Latini P, Tonato M.

Am J Clin Oncol. 1996 Feb;19(1):10-7.

PMID:
8554028
19.

Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.

Reboul F, Brewer Y, Vincent P, Chauvet B, Faure CF, Taulelle M.

Int J Radiat Oncol Biol Phys. 1996 May 1;35(2):343-50.

PMID:
8635942
20.

Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.

Athanasiadis I, Taylor S 4th, Vokes EE, Pelzer HJ, Rademaker A, Mittal BB, Ganzenko N, Blough R, Lester EP, Kies MS.

Cancer. 1997 Feb 1;79(3):588-94.

PMID:
9028372

Supplemental Content

Support Center